48 Results for "

gallbladder

" in MedChemExpress (MCE) Product Catalog:
Products (48)

48 Results for "gallbladder" in MCE Product Catalog:

145
145 Publications Verification
Art. -Nr.: HY-A0190
CAS. Nr.: 17650-98-5
Synonyms: Ceruletide; Cerulein; FI-6934
Caerulein is a decapeptide and a potent cholecystokinin receptor agonist. Caerulein is a safe and effective cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts .
loading...
    loading...
13
13 Cited Publications
Art. -Nr.: HY-136453
CAS. Nr.: 1352914-52-3
Reinheit:  98.38%
Forschungsgebiete:  

Cancer

CR-1-31-B is a synthetic rocaglate and a potent eIF4A inhibitor. CR-1-31-B exhibits powerful inhibitory effects over eIF4A by perturbing the interaction between eIF4A and RNA, sequentially impeding initiation during protein synthesis. CR-1-31-B perturbs association of Plasmodium falciparum eIF4A (PfeIF4A) with RNA. CR-1-31-B induces apoptosis of neuroblastoma and gallbladder cancer cells .
loading...
    loading...
6
6 Cited Publications
Art. -Nr.: HY-106301
CAS. Nr.: 103420-77-5
Reinheit:  99.55%
Synonyms: L-364,718; MK-329
Forschungsgebiete:  

Metabolic Disease

Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide (L-364,718) is effective for gastrointestinal disorders .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-P0093
CAS. Nr.: 25126-32-3
Synonyms: Cholecystokinin octapeptide; CCK-8; SQ19844
Forschungsgebiete:  

Infection Cancer

Sincalide (Cholecystokinin octapeptide, CCK-8) is a rapid-acting amino acid polypeptide hormone analogue of cholecystokinin (CCK) for intravenous use in postevacuation cholecystography. Sincalide is a major bioactive segment of CCK that retains most of the biological activities of CCK. Sincalide can promote gallbladder contraction by injection and helps diagnose gallbladder and pancreas disorders. Sincalide can increase bile secretion, cause the gallbladder to contract and relax the sphincter of Oddi, resulting in bile drainage into the duodenum. Sincalide is a major bioactive segment of CCK that retains most of the biological activities of CCK .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-P0093A
CAS. Nr.: 70706-98-8
Synonyms: Cholecystokinin octapeptide ammonium; CCK-8 ammonium; SQ19844 ammonium
Forschungsgebiete:  

Infection Cancer

Sincalide ammonium (Cholecystokinin octapeptide ammonium, CCK-8 ammonium) is a rapid-acting amino acid polypeptide hormone analogue of cholecystokinin (CCK) for intravenous use in postevacuation cholecystography. Sincalide ammonium is a major bioactive segment of CCK that retains most of the biological activities of CCK. CCK‐8 can promote gallbladder contraction by injection and helps diagnose gallbladder and pancreas disorders. Sincalide ammonium can increase bile secretion, cause the gallbladder to contract and relax the sphincter of Oddi, resulting in bile drainage into the duodenum. Sincalide ammonium is a major bioactive segment of CCK that retains most of the biological activities of CCK .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-B1292
CAS. Nr.: 606-17-7
Synonyms: Adipiodone
Forschungsgebiete:  

Inflammation/Immunology

Iodipamide (Adipiodone) is an ionic iodinated contrast agent. Iodipamide is used for diagnostic imaging to visualize the bile ducts and gallbladder during X-ray examinations .
loading...
    loading...
Art. -Nr.: HY-137255
CAS. Nr.: 64936-83-0
Synonyms: 3-Sulfotaurolithocholic acid disodium
Taurolithocholic acid 3-sulfate disodium is a GPR39 agonist with EC50s of 71.6  and 69.4 (absence of Zn 2+) and 9 and 9.6 μM (presence of Zn 2+) in M39-20 and hGPR39-2 cells, respectively. Taurolithocholic acid 3-sulfate disodium stimulates GPR39 receptors to initiate intracellular calcium signaling, independent of Zn 2+ binding sites H17 and H19. Taurolithocholic acid 3-sulfate disodium can be used for the research of gallbladder disease .
loading...
    loading...
Art. -Nr.: HY-134508
CAS. Nr.: 34435-05-7
Reinheit:  99.92%
C24-Ceramide is an orally active competitive binding agonist of PIP4K2C (mTOR complex regulator), thereby activating the mTOR signaling pathway. At the same time, C24-Ceramide changes the membrane morphology by inducing the formation of a partially interlocked gel phase in the phospholipid bilayer. C24-Ceramide can promote the proliferation and migration of keratinocytes to accelerate skin wound healing and drive the proliferation and metastasis of gallbladder cancer cells. The level of C24-Ceramide in serum can be used as a diagnostic marker for gallbladder cancer .
loading...
    loading...
Art. -Nr.: HY-113074
CAS. Nr.: 15324-64-8
Reinheit:  ≥98.0%
Synonyms: Glycolithocholate sulfate; Sulfolithocholylglycine; SLCG
Glycolithocholic acid 3-sulfate (SLCG) is a cholic acid derivative and a metabolite of glycolithocholic acid. Glycolithocholic acid 3-sulfate inhibits replication of HIV-1 in vitro. Glycolithocholic acid 3-sulfate can be used for the research of HIV infection and gallbladder disease .
loading...
    loading...
Art. -Nr.: HY-145601
CAS. Nr.: 2230490-29-4
Reinheit:  98.45%
Synonyms: TT 00420
Target:  

Aurora Kinase FGFR VEGFR

Forschungsgebiete:  

Cancer

Tinengotinib (TT00420) is an orally active, spectrally selective small molecule kinase inhibitor targeting Aurora A/B (IC50=1.2-3.3 nM), FGFR1/2/3 (IC50=1.5-3.5 nM), VEGFRs, JAK1/2 and CSF1R. Tinengotinib blocks Aurora kinase-mediated cell cycle progression (inducing G2/M arrest), inhibits FGFR/JNK-JUN signaling pathway and activates MEK/ERK-dependent apoptotic pathway. Tinengotinib has the activity of anti-tumor proliferation, inducing apoptosis, inhibiting angiogenesis and regulating tumor microenvironment. Tinengotinib can be used in the study of triple-negative breast cancer (TNBC), gallbladder cancer and tumor immune microenvironment .
loading...
    loading...
Art. -Nr.: HY-P3651
CAS. Nr.: 103974-46-5
Synonyms: CCK (26-33) free acid
Target:  

Peptides

Forschungsgebiete:  

Metabolic Disease

Cholecystokinin (26-33) (CCK (26-33)) free acid is a cholecystokinin (CCK) fragment. Cholecystokinin (26-33) free acid can reduce food intake and gallbladder contraction .
loading...
    loading...
Art. -Nr.: HY-W587430
CAS. Nr.: 64936-82-9
Synonyms: Glycolithocholate sulfate disodium; Sulfolithocholylglycine disodium; SLCG disodium
Target:  

HIV GPR39

Forschungsgebiete:  

Infection Inflammation/Immunology

Glycolithocholic acid 3-sulfate disodium is a GPR39 agonist with EC50s of 47.9  and 66.8 μM (absence of Zn 2+) and 8 and 8.7 μM (presence of Zn 2+) in M39-20 and hGPR39-2 cells, respectively. Glycolithocholic acid 3-sulfate disodium stimulates GPR39 receptors to initiate intracellular calcium signaling, independent of Zn 2+ binding sites H17 and H19. Glycolithocholic acid 3-sulfate disodium also inhibits replication of HIV-1 in vitro. Glycolithocholic acid 3-sulfate disodium can be used for the research of HIV infection and gallbladder disease .
loading...
    loading...
Art. -Nr.: HY-W588187
CAS. Nr.: 601-53-6
Synonyms: 5β-Cholestan-3-one
Forschungsgebiete:  

Cancer

Coprostanone (5β-cholestan-3-one) is an oxysterol and active metabolite of Cholesterol (HY-N0322). Coprostanone induces apoptosis in primary dog gallbladder epithelial cells. Coprostanone is promising for research of colon cancers or adenomatous polyps .
loading...
    loading...
Art. -Nr.: HY-121799A
CAS. Nr.: 117997-17-8
Reinheit:  96.8%
Synonyms: THCA sodium salt
Target:  

Endogenous Metabolite

Forschungsgebiete:  

Others

Taurohyocholic acid (THCA) sodium salt is a taurine-conjugated hyocholic acid. Taurohyocholic acid sodium salt is predictor of the efficacy of tyrosine kinase inhibitors combined withPD-1 inhibitors in hepatocellular carcinoma (HCC) .
loading...
    loading...
Art. -Nr.: HY-101764
CAS. Nr.: 136381-85-6
Reinheit:  ≥99.0%
Synonyms: SR 27897
Forschungsgebiete:  

Metabolic Disease

Lintitript (SR 27897) is a highly potent, selective, orally active, competitive and non-peptide cholecystokinin (CCK1) receptor antagonist with an EC50 of 6 nM and a Ki of 0.2 nM. Lintitript displays > 33-fold selectivity more selective for CCK1 than CCK2 receptors (EC50 value of 200 nM). Lintitript increases plasma concentration of leptin and food intake as well as plasma concentration of insulin .
loading...
    loading...
Art. -Nr.: HY-19261
CAS. Nr.: 169042-78-8
Forschungsgebiete:  

Metabolic Disease

T-0632 is a CCK A receptor antagonist that exhibits significant pharmacological properties in in vitro studies. T-0632 competitively inhibits the binding of [125I]CCK-8 to rat pancreatic CCK A receptors with a K_i value of 0.24 nM, which is significantly lower than the K_i value for guinea pig CCK B receptors. T-0632 has higher selectivity in inhibiting CCK-8-stimulated pancreatic enzyme release, with an IC_50 value of 5.0 nM, which is more advantageous than L-364,718 and loxiglumide. In rabbit gallbladder smooth muscle, the antagonistic effects of T-0632 and loxiglumide are reversible, while L-364,718 shows a persistent inhibitory effect. These results indicate that T-0632 is a highly potent, reversible and more selective CCK A receptor antagonist.
loading...
    loading...
Art. -Nr.: HY-146453
CAS. Nr.: 2643391-08-4
Forschungsgebiete:  

Metabolic Disease

TGR5 Receptor Agonist 3 (Compound 19) is a soft-agent G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonist with reduced gallbladder-filling effects (favorable gallbladder safety), with EC50s of 16.4 and 209 nM for hTGR5 and mTGR5, respectively.
loading...
    loading...
Art. -Nr.: HY-106380
CAS. Nr.: 122254-45-9
Synonyms: HR 780
Forschungsgebiete:  

Metabolic Disease

Glenvastatin (HR 780) is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor. Glenvastatin can reduces plasma total cholesterol and phospholipid levels and liver cholesterol contents. Glenvastatin does not increase the contents of cholesterol and total bile acid in the gallbladder bile. Glenvastatin can be used for the research of hyperlipemia
loading...
    loading...
Art. -Nr.: HY-P3652
CAS. Nr.: 67256-27-3
Forschungsgebiete:  

Metabolic Disease

Cholecystokinin-33 (swine) is a cholecystokinin (CCK) fragment. Cholecystokinin-33 (swine) can reduce food intake and gallbladder contraction .
loading...
    loading...
Art. -Nr.: HY-P2636
CAS. Nr.: 99291-20-0
Synonyms: Prepro CCK Fragment V-9-M
Target:  

Histamine Receptor

Forschungsgebiete:  

Metabolic Disease

Cholecystokinin Precursor (24-32) (rat) is a cholecystokinin precursor that can be expressed in the heart, lungs, and kidneys as well as in the gastrointestinal tract and brain. Cholecystokinin is a brain-gut peptide that stimulates gallbladder contraction and pancreatic exocrine secretion and also acts as a neurotransmitter .
loading...
    loading...